Genomics News and Research

RSS

Genomics is the study of the complete genetic material, including genes and their functions, of an organism.

New web-based service for analyzing, visualizing and managing DNA sequencing data

DNAnexus, Inc. today announced the commercial launch of its web-based service for analyzing, visualizing, and managing next-generation DNA sequencing data. Andreas Sundquist, Ph.D., co-founder and CEO, will introduce the solution publicly for the first time today at the annual Bio-IT World Conference and Expo in Boston, Massachusetts.

20 Apr 2010

Sigma Life Science announces global release of CompoZr Targeted Integration Kit

Sigma® Life Science, the innovative biological products and services brand of Sigma-Aldrich®, today announced an extension to its award-winning CompoZr® product offering with the global release of the CompoZr Targeted Integration Kit, AAVS1. This kit provides a powerful method for the controlled transgene integration and expression of any gene in any human cell line using Sigma-Aldrich's proprietary CompoZr Zinc Finger Nuclease (ZFN) technology.

20 Apr 2010

Agilent Technologies introduces user-friendly genomics Web site

Agilent Technologies Inc. today introduced a dynamic and user-friendly genomics Web site, genomics.agilent.com.

20 Apr 2010

Updated survival data from Phase I/II trial of nab-paclitaxel, gemcitabine combination for pancreatic cancer

Abraxis BioScience, Inc., a fully integrated biotechnology company, today announced updated overall survival findings from a phase I/II study of nab®-paclitaxel (ABRAXANE® for Injectable Suspension) (paclitaxel protein-bound particles for injectable suspension) (albumin-bound) given in combination with gemcitabine, demonstrated increased survival of the first-line treatment of patients with advanced pancreatic cancer.

19 Apr 2010

Potential mate's signal activates molecular switch

A mystery about the mechanism behind sexual mate selection has been resolved. According to a new study published in the journal Nature, Universit- de Montr-al researchers have discovered a molecular switch that becomes activated in response to a potential mate's signal. Simply put, an organism knows that a potential mate is close-by and healthy enough to mate.

19 Apr 2010

New insights into yeast cells may help identify cancer cells and stem cells development: Study

Yeast cells decide whether to have sex with each other within two minutes of meeting, according to new research published today in Nature. One of the authors of the study, from Imperial College London, says the new insights into how yeast cells decide to mate could be helpful for researchers looking at how cancer cells and stem cells develop.

19 Apr 2010

New p53 knockout rat model improves timelines for carcinogenicity screening

Sigma Life Science, the innovative biological products and services brand of Sigma-Aldrich, today introduced the world's first p53 'knockout' rat model, an important development that is expected to, due to the rat's closer physiological and metabolic similarity to humans, significantly improve timelines for carcinogenicity screening and reduce time to market for therapeutics.

19 Apr 2010

TGen, Asuragen sign microRNA technology agreement for pancreatic cancer research

The Translational Genomics Research Institute and Asuragen Inc. today announced a research agreement that could lead to ways of detecting cancer before it spreads.

17 Apr 2010

Illumina announces first named family DNA sequence

Illumina, Inc. today announced that it has sequenced the DNA of John, Judy, Anne and Paul West, the first publicly named family to have their DNA sequenced to full coverage by the company.

From Illumina, Inc. 17 Apr 2010

Genome Alberta launches competition for bovine and swine genomics research projects

Genome Alberta has launched a competition for bovine and swine genomics research projects that will contribute to the success and growth of Alberta's highly competitive livestock and meat industry. This Competition is open to researchers based at provincial, national or international research institutions and private industry, but must be led or co-led by an Alberta or Canadian Investigator.

16 Apr 2010

Research may provide better clinical outcomes for patients with aggressive type of brain cancer

A study conducted by a collaborative team led by researchers from the University of Southern California (USC) may lead to better insight into the clinical outcome for some patients with a particularly aggressive type of brain cancer. The research may also provide a framework for development of targeted drug treatments.

16 Apr 2010

Exclusive licensing practices slows innovation in gene testing market

Exclusive licenses to gene patents, most of which are held by academic institutions and based on taxpayer-funded research, do more to block competition in the gene testing market than to spur the development of new technologies for gauging disease risk, say researchers at the Duke Institute for Genome Sciences & Policy (IGSP).

15 Apr 2010

Foundation Medicine completes $25M Series A financing led by Third Rock Ventures

Foundation Medicine, a personalized cancer medicine company that aims to bring comprehensive cancer genome analysis into routine clinical care, today announced it has completed a $25 million Series A financing led by Third Rock Ventures.

15 Apr 2010

Study provides support for relationship between APOE4 gene and risk of Alzheimer's disease in Latinos

A brain-imaging study published today in the Archives of Neurology suggests that a major genetic risk factor for Alzheimer's disease in the Anglo population is also a risk factor for the disease in Latinos.

15 Apr 2010

Researchers identify gene that appears to increase risk of Alzheimer's disease

Researchers have identified a gene that appears to increase a person's risk of developing late-onset Alzheimer's disease, the most common type of Alzheimer's disease. The research will be presented as part of the late-breaking science program at the American Academy of Neurology's 62nd Annual Meeting in Toronto, April 10 - 17, 2010.

15 Apr 2010

Australian scientists sequence genome of pancreatic cancer

The International Cancer Genome Consortium which includes researchers from 22 countries is mapping the genomes of different types of cancers. A genome is essentially a blueprint of a human’s DNA. The genetic data of each individual is different and so is the genetic data of the cancer in the individual. The Australian scientists are sequencing the genomes of people suffering from pancreatic cancer.

15 Apr 2010

Sigma Life Science announces latest version of 'Your Favorite Gene Powered By Ingenuity' research portal

Sigma® Life Science, the innovative biological products and services brand of Sigma-Aldrich®, today announced a significant expansion to its web-based biological research portal for exploring dynamic gene-based content, Your Favorite Gene Powered By Ingenuity (http://www.wherebiobegins.com/yfg).

13 Apr 2010

TD2, Horizon Discovery announce strategic alliance to advance personalized medicine

A strategic alliance announced today between TGen Drug Development (TD2) and Horizon Discovery Limited will significant advance personalized medicine.

13 Apr 2010

The EMBO Meeting 2010: Over 120 researchers to present

More than 120 leading researchers from across the molecular life sciences will speak at The EMBO Meeting 2010 - the second annual life sciences conference to be organized by the European Molecular Biology Organization (EMBO) and held in Barcelona from 4 - 7 September 2010.

13 Apr 2010

Antidepressants and mood stabilizers may benefit stroke victims

A study in rodents shows the growth of new neurons, also known as neurogenesis, lessens the severity of stroke and dramatically improves function following a stroke. The research, undertaken at the Buck Institute for Age Research, suggests that drugs shown to promote neurogenesis in rodents could have benefits for human stroke victims and that those drugs-which include antidepressants and mood stabilizers such as lithium-may be suitable for study in human clinical trials.

13 Apr 2010

Genomics News and Research

Further Reading

New web-based service for analyzing, visualizing and managing DNA sequencing data

Sigma Life Science announces global release of CompoZr Targeted Integration Kit

Agilent Technologies introduces user-friendly genomics Web site

Updated survival data from Phase I/II trial of nab-paclitaxel, gemcitabine combination for pancreatic cancer

Potential mate's signal activates molecular switch

New insights into yeast cells may help identify cancer cells and stem cells development: Study

New p53 knockout rat model improves timelines for carcinogenicity screening

TGen, Asuragen sign microRNA technology agreement for pancreatic cancer research

Illumina announces first named family DNA sequence

Genome Alberta launches competition for bovine and swine genomics research projects

Research may provide better clinical outcomes for patients with aggressive type of brain cancer

Exclusive licensing practices slows innovation in gene testing market

Foundation Medicine completes $25M Series A financing led by Third Rock Ventures

Study provides support for relationship between APOE4 gene and risk of Alzheimer's disease in Latinos

Researchers identify gene that appears to increase risk of Alzheimer's disease

Australian scientists sequence genome of pancreatic cancer

Sigma Life Science announces latest version of 'Your Favorite Gene Powered By Ingenuity' research portal

TD2, Horizon Discovery announce strategic alliance to advance personalized medicine

The EMBO Meeting 2010: Over 120 researchers to present

Antidepressants and mood stabilizers may benefit stroke victims

Sequencing & Genomics: Elevating Science and Healthcare eBook

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Latest Life Science News